FIELD: medicine, pharmaceutics.
SUBSTANCE: there are described new camptothecin derivatives, i.e. 4,5-dihydrotriazolyl [5,4-c]16a-deoxocamptothecin and triazolyl[5,4-c]16a-deoxocamptothecin showing anticancer activity, a pharmaceutical composition containing them and applying them as anticancer drugs.
EFFECT: preparing the anticancer pharmaceutical composition.
5 cl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CAMPTOTHECIN DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2450007C2 |
| CAMPTOTHECIN DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2450008C2 |
| HETEROCYCLIC COMPOUNDS HAVING AFFINITY TO MUSCARINE RECEPTORS | 2008 |
|
RU2446166C2 |
| 2-PYRIDONE DERIVATIVES | 2010 |
|
RU2551847C2 |
| PYRIDYL DIMETHYLSULPHONIC DERIVATIVE | 2006 |
|
RU2404968C2 |
| HEXACYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND THEIR USING AS ANTITUMOR AGENTS, METHOD FOR PREPARING HEXACYCLIC COMPOUNDS | 2002 |
|
RU2299212C2 |
| VARIOLINE DERIVATIVES AND THEIR EMPLOYMENT AS ANTITUMOR AGENTS | 2002 |
|
RU2302419C2 |
| INHIBITORS OF TWO SITES OF BINDING ACETYLCHOLINESTERASE FOR TREATMENT OF THE ALZHEIMER'S DISEASE | 2003 |
|
RU2325379C2 |
| 2-PYRIDYL-SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS | 2011 |
|
RU2518069C1 |
| NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES INHIBITORS | 2003 |
|
RU2330042C2 |
